| Tri-state Ophthalmology Associates Psc | |
|
2841 Lexington Ave, Ashland, KY 41101-3009 | |
| (606) 324-2451 | |
| (606) 324-7123 |
| Full Name | Tri-state Ophthalmology Associates Psc |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 2841 Lexington Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245261833 | NPI | - | NPPES |
| 2115848 | Medicaid | OH | |
| 65931172 | Medicaid | KY | |
| CA4418 | Other | KY | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Secondary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Primary |
| Provider Name | John C Gross |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1245209550 PECOS PAC ID: 4284682428 Enrollment ID: I20051123000005 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.
The Society of NeuroInterventional Surgery's (SNIS) Patient Safety Organization (PSO), in partnership with the NeuroPoint Alliance (NPA), is pleased to announce that the NVQI-QOD now has over 10,000 procedures in the registry.
About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence
› Verified 4 days ago
| Provider Name | Carter H Gussler |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1215905393 PECOS PAC ID: 3173543402 Enrollment ID: I20051201000782 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.
The Society of NeuroInterventional Surgery's (SNIS) Patient Safety Organization (PSO), in partnership with the NeuroPoint Alliance (NPA), is pleased to announce that the NVQI-QOD now has over 10,000 procedures in the registry.
About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence
› Verified 4 days ago
| Provider Name | Joshua Daniel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1407101439 PECOS PAC ID: 6507014131 Enrollment ID: I20120924000426 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.
The Society of NeuroInterventional Surgery's (SNIS) Patient Safety Organization (PSO), in partnership with the NeuroPoint Alliance (NPA), is pleased to announce that the NVQI-QOD now has over 10,000 procedures in the registry.
About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence
› Verified 4 days ago
| Provider Name | Joshua C Gross |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1144649914 PECOS PAC ID: 6204100647 Enrollment ID: I20200702000570 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.
The Society of NeuroInterventional Surgery's (SNIS) Patient Safety Organization (PSO), in partnership with the NeuroPoint Alliance (NPA), is pleased to announce that the NVQI-QOD now has over 10,000 procedures in the registry.
About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence
› Verified 4 days ago
| Provider Name | Cody Williams |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1376003145 PECOS PAC ID: 0143646281 Enrollment ID: I20230816000378 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.
The Society of NeuroInterventional Surgery's (SNIS) Patient Safety Organization (PSO), in partnership with the NeuroPoint Alliance (NPA), is pleased to announce that the NVQI-QOD now has over 10,000 procedures in the registry.
About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tri-state Ophthalmology Associates Psc 2841 Lexington Avenue, Ashland, KY 41101 Ph: (606) 324-2451 | Tri-state Ophthalmology Associates Psc 2841 Lexington Ave, Ashland, KY 41101-3009 Ph: (606) 324-2451 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.
The Society of NeuroInterventional Surgery's (SNIS) Patient Safety Organization (PSO), in partnership with the NeuroPoint Alliance (NPA), is pleased to announce that the NVQI-QOD now has over 10,000 procedures in the registry.
About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence
› Verified 4 days ago